BASIS OF PRESENTATION, SIGNIFICANT CONCENTRATION AND RISKS (Narrative) (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2015 USD ($) item	Jun. 30, 2014 item	Jun. 30, 2015 USD ($) item	Jun. 30, 2014 item	Dec. 31, 2014 USD ($) item
Basis Of Presentation Significant Concentration And Risk [Line Items]
Total cash at banks and deposits including insured amount | $	$ 178,482,788		$ 178,482,788		$ 184,186,306
Cash, Insured Amount | $	$ 2,952,780		$ 2,952,780		$ 86,744
Customers represented 10% or more of accounts receivables	1		1		0
Customers that individually comprised 10% or more of the total sales	0	0	0	0
Suppliers that comprised 10% or more of the total purchases	0	0	0	0
Suppliers that represented more than 10% of accounts payables	0		0		0
Human Albumin [Member]
Basis Of Presentation Significant Concentration And Risk [Line Items]
Major product sales percentage	35.70%	34.10%	36.90%	38.10%
Human Immunoglobulin For Intravenous Injection [Member]
Basis Of Presentation Significant Concentration And Risk [Line Items]
Major product sales percentage	43.10%	44.00%	44.80%	40.40%